DNA and its associated processes as targets for cancer therapy (original) (raw)

• Slapak, C. A. & Kufe, D. W. in Harrison's Principles of Internal Medicine 14th edn (eds Isselbacher, K. J. et al.) 523–537 (McGraw–Hill, Inc. (Health Professions Div., New York, 1998).
  Google Scholar
• Druker, B. J. et al. Efficacy and safety of a specific inhibitor of the BCR–ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344, 1031–1037 (2001).
  Article CAS PubMed Google Scholar
• Kohn, K. Beyond DNA cross-linking: history and prospects of DNA–targeted cancer treatment. Fifteenth Bruce F. Cain Memorial Award Lecture. Cancer Res. 56, 5533–5546 (1996).
  CAS PubMed Google Scholar
• Infield, G. B. Disaster at Bari (Macmillan, New York, 1971).
  Google Scholar
• Ward, K. Jr. The chlorinated ethylamines: a new type of vesicant. J. Am. Chem. Soc. 57, 914–916 (1935).
  Article CAS Google Scholar
• Gilman, A. & Philips, F. S. The biological actions and therapeutic applications of β-chloroethyl amines and sulfides. Science 103, 409–415 (1946).
  Article CAS PubMed Google Scholar
• Goodman, L. S., Wintrobe, M. M., Dameshek, W., Goodman, J. J. & Gilman, A. Nitrogen mustard therapy. Use of methyl-bis(β-chloroethylamine hydrocholoride) and tris(β–chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. JAMA 132, 126–132 (1946).The first report of clinical results from 67 patients treated with nitrogen mustards for Hodgkin's disease, lymphosarcoma and leukaemia. Some marked improvements were found, but the margin of safety was narrow.
  Article CAS Google Scholar
• Clark, A. S. et al. Antitumor imidazotetrazines. 32. Synthesis of novel imidazotetrazinones and related bicyclic heterocycles to probe the mode of action of the antitumor drug temozolomide. J. Med. Chem. 38, 1493–1504 (1995).
  Article CAS PubMed Google Scholar
• Goldacre, R. J., Loveless, A. & Ross, W. C. The mode of production of chromosome abnormalities by nitrogen mustard: possible role of crosslinking. Nature 163, 667–669 (1949).
  Article CAS PubMed Google Scholar
• Wang, K., Ramji, S., Bhathena, A., Lee, C. & Riddick, D. S. Glutathione _S_-transferases in wild-type and doxorubicin-resistant MCF-7 human breast cancer cell lines. Xenobiotica 29, 155–170 (1999).
  Article CAS PubMed Google Scholar
• Smith, S. Technology evaluation: SGN–15, Seattle Genetics Inc. Curr. Opin. Mol. Ther. 3, 295–302 (2001).
  CAS PubMed Google Scholar
• Syrigos, K. N. & Epenetos, A. A. Antibody directed enzyme prodrug therapy (ADEPT): a review of the experimental and clinical considerations. Anticancer Res. 19, 605–613 (1999).
  CAS PubMed Google Scholar
• Dorr, R. T. & Von Hoff, D. D. Cancer Chemotherapy Handbook (Appleton & Lange, Norwalk, Connecticut, 1994).
  Google Scholar
• Gottesfeld, J. M., Turner, J. M. & Dervan, P. B. Chemical approaches to control gene expression. Gene Expr. 9, 77–91 (2000).
  Article CAS PubMed Google Scholar
• Giovannangeli, C. & Hélène, C. Triplex-forming molecules for modulation of DNA information processing. Curr. Opin. Mol. Ther. 2, 288–297 (2000).
  CAS PubMed Google Scholar
• Neidle, S. The molecular basis for the action of some DNA-binding drugs. Prog. Med. Chem. 16, 151–221 (1979).
  Article CAS PubMed Google Scholar
• Minford, J. et al. Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as topoisomerase II. Biochemistry 25, 9–16 (1986).The protein linked to the intercalator DNA strand-cleaved product was shown to be topoisomerase II.
  Article CAS PubMed Google Scholar
• Tewey, K. M., Rowe, T. C., Yang, L., Halligan, B. D. & Liu, L. F. Adriamycin-induced DNA damage mediate by mammalian DNA topoisomerase II. Science 226, 466–468 (1984).In a cell-free system, doxorubicin is shown to produce topoisomerase-II-mediated cleavage of DNA, inferring that this drug affects the breakage–reunion reaction by stabilizing the cleavable complex.
  Article CAS PubMed Google Scholar
• Henderson, D. & Hurley, L. H. Molecular struggle for transcriptional control. Nature Med. 1, 525–527 (1995).
  Article CAS PubMed Google Scholar
• Zhong, D., Pal, S. K., Wan, C. & Zewail, A. H. Femtosecond dynamics of a drug–protein complex: daunomycin with Apo riboflavin-binding protein. Proc. Natl Acad. Sci. USA 98, 11873–11878 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Reich, E. & Goldberg, I. H. Actinomycin and nucleic acid function. Prog. Nucleic Acid Res. Mol. Biol. 3, 183–234 (1964).
  Article CAS PubMed Google Scholar
• Muller, W. & Crothers, D. M. Studies of the binding of actinomycin and related compounds to DNA. J. Mol. Biol. 35, 251–290 (1968).
  Article CAS PubMed Google Scholar
• Sobell, H. M., Jain, S. C., Sakore, T. D. & Nordman, C. E. Stereochemistry of actinomycin–DNA binding. Nature New Biol. 231, 200–205 (1971).
  Article CAS PubMed Google Scholar
• Zimmer, C. & Wahnert, U. Nonintercalating DNA-binding ligands: specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material. Prog. Biophys. Mol. Biol. 47, 31–112 (1986).
  Article CAS PubMed Google Scholar
• Thuong, N. & Hélène, C. Sequence specific recognition and modification of double helical DNA by oligonucleotides. Angew. Chem. Int. Ed. Engl. 32, 666–690 (1993).
  Article Google Scholar
• Strobel, S. A., Doucette–Stamm, L. A., Riba, L., Houseman, D. E. & Dervan, P. B. Site specific cleavage of human chromosome 4 mediated by triple helix formation. Science 254, 1639–1642 (1991).
  Article CAS PubMed Google Scholar
• Gellert, M., Lipsett, M. N. & Davies, D. R. Helix formation by guanylic acid. Proc. Natl Acad. Sci. USA 48, 2013–2018 (1962).
  Article CAS PubMed PubMed Central Google Scholar
• Han, H. & Hurley, L. H. G-quadruplex DNA: a potential target for anti-cancer drug design. Trends Pharmacol. Sci. 21, 136–142 (2000).
  Article CAS PubMed Google Scholar
• Kerwin, S. M. G-quadruplex DNA as a target for drug design. Curr. Pharm. Des. 6, 441–471 (2000).
  Article CAS PubMed Google Scholar
• Sun, D. et al. Inhibition of human telomerase by a G-quadruplex-interactive compound. J. Med. Chem. 40, 2113–2116 (1997).
  Article CAS PubMed Google Scholar
• Broggini, M. & D'Incalci, M. Modulation of transcription factor–DNA interactions by anticancer drugs. Anticancer Drug Des 9, 373–387 (1994).
  CAS PubMed Google Scholar
• Gniazdowski, M. & Czyz, M. Transcription factors as targets of anticancer drugs. Acta Biochim. Pol. 46, 255–262 (1999).
  Article CAS PubMed Google Scholar
• Wang, J. C. DNA topoisomerases. Annu. Rev. Biochem. 65, 635–692 (1996).
  Article CAS PubMed Google Scholar
• Pourquier, P. & Pommier, Y. Topoisomerase I-mediated DNA damage. Adv. Cancer Res. 80, 189–216 (2001).
  Article CAS PubMed Google Scholar
• Nitiss, J. L. Investigating the biological functions of DNA topoisomerase in eukaryotic cells. Biochim. Biophys. Acta 1400, 63–81 (1998).
  Article CAS PubMed Google Scholar
• Vladu, B. et al. 7- and 10-substituted camptothecins: dependence of topoisomerase I–DNA cleavable complex formation and stability on the 7- and 10-substituents. Mol. Pharmacol. 57, 243–251 (2000).
  CAS PubMed Google Scholar
• Pommier, Y. in Cancer Therapeutics: Experimental and Clinical Agents (ed. Teicher, B. A.) 153–173 (Humana, Totowa, New Jersey, 1997).
  Book Google Scholar
• Rosenberg, B. & Camp, L. V. Inhibition of cell division in Escherichia coli by electrolysis products from a platinum electrode. Nature 205, 698–699 (1965).
  Article CAS PubMed Google Scholar
• Bellon, S. F., Coleman, J. H. & Lippard, S. J. DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug _cis_-diamminedichloroplatinum(II). Biochemistry 30, 8026–8035 (1991).
  Article CAS PubMed Google Scholar
• Brown, S. J., Kellett, P. J. & Lippard, S. J. Ixr1, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin. Science 261, 603–605 (1993).
  Article CAS PubMed Google Scholar
• Treiber, D. K., Zhai, X., Jantzen, H.-M. & Essigmann, J. M. Cisplatin–DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor). Proc. Natl Acad. Sci. USA 91, 5672–5676 (1994).The authors introduce the idea that drugs that distort DNA, such as cisplatin, might result in high-affinity binding sites for transcriptional factors and so act as molecular decoys for them.
  Article CAS PubMed PubMed Central Google Scholar
• Jamieson, E. R. & Lippard, S. J. Structure, recognition, and processing of cisplatin–DNA adducts. Chem. Rev. 99, 2467–2498 (1999).
  Article CAS PubMed Google Scholar
• Thompson, A. S., Sun, D. & Hurley, L. H. Monoalkylation and cross-linking of DNA by cyclopropapyrroloindoles entraps bent and straight forms of A-tract. J. Am. Chem. Soc. 117, 2371–2372 (1995).
  Article CAS Google Scholar
• Sun, D. & Hurley, L. H. Cooperative bending of the 21-base-pair repeats of the SV40 viral early promoter by human Sp1. Biochemistry 33, 9578–9587 (1994).
  Article CAS PubMed Google Scholar
• Rinehart, K. L. et al. Ecteinascidins 729, 743, 745, 759A, 759B, and 770: potent antitumor agents from the Caribbean tunicate Ecteinascidia turbinate. J. Org. Chem. 55, 4512–4515 (1990).
  Article CAS Google Scholar
• Zewail-Foote, M. et al. The inefficiency of incisions of Ecteinascidin 743–DNA adducts by the UvrABC nuclease and the unique structural feature of the DNA adducts can be used to explain the repair-dependent toxicities of this antitumor agent. Chem. Biol. 8, 1033–1049 (2001).
  Article CAS PubMed Google Scholar
• Garcia-Nieto, R., Manzanares, I., Cuevas, C. & Gago, F. Increased DNA binding specificity for antitumor ecteinascidin 743 through protein–DNA interactions? J. Med. Chem. 43, 4367–4369 (2000).
  Article CAS PubMed Google Scholar
• Zewail-Foote, M. & Hurley, L. H. Ecteinascidin 743: a minor groove alkylator that bends DNA toward the major groove. J. Med. Chem. 42, 2943–2947 (1999). | PubMed |
  Article CAS Google Scholar
• Takebayashi, Y. et al. Antiproliferative activity of Ecteinascidin 743 is dependent upon transcription-coupled nucleotide-excision repair. Nature Med. 7, 961–966 (2001).The unique mechanism of action of Et-743 is shown to involve TC-NER: the drug-trapped complex results in single-stranded breaks in DNA.
  Article CAS PubMed Google Scholar
• Erba, E. et al. Ecteinascidin-743 (ET–743), a natural marine compound, with a unique mechanism of action. Eur. J. Cancer 37, 97–105 (2001).
  Article CAS PubMed Google Scholar
• Reed, E. Platinum–DNA adduct, nucleotide excision repair, and platinum-based anti-cancer chemotherapy. Cancer Treat. Rev. 24, 331–344 (1998).
  Article CAS PubMed Google Scholar
• Jin, S. Gorfajn, B., Faircloth, G. & Scotto, K. W. Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation. Proc. Natl Acad. Sci. USA 97, 6775–6779 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Synold, T. W., Dussault, I. & Forman, B. M. The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux. Nature Med. 7, 584–590 (2001).
  Article CAS PubMed Google Scholar
• Minuzzo, M. et al. Interference of transcriptional activation by the antineoplastic drug Ecteinascidin-743. Proc. Natl Acad. Sci. USA 97, 6780–6784 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Hansen, M. & Hurley, L. H. Pluramycins. Old drugs having modern friends in structural biology. Acc. Chem. Res. 29, 249–258 (1996).
  Article CAS Google Scholar
• Hélène, C. Sequence-selective recognition and cleavage of double-helical DNA. Curr. Opin. Biotechnol. 4, 29–36 (1993).
  Article PubMed Google Scholar
• Pelton, J. G. & Wemmer, D. E. Structural characterization of a 2-1 distamycin A●d(CGCAAATTTGGC)2 complex by two-dimensional NMR. Proc. Natl Acad. Sci. USA 86, 5723–5727 (1989). The first report of the side-by-side or 2:1 ligand:DNA complex that was determined by nuclear magnetic resonance. This was the clue that the Dervan lab needed to explain the unexpected footprinting pattern observed in gels in which the same 2:1 antiparallel side-by-side dimer was present (see reference 90).
  Article CAS PubMed PubMed Central Google Scholar
• Dervan, P. B. & Bürli, R. W. Sequence-specific DNA recognition by polyamides. Curr Opin Chem Biol 3, 688–693 (1999).
  Article CAS PubMed Google Scholar
• Trauger, J. W., Baird, E. E., Mrksich, M. & Dervan, P. B. Extension of sequence-specific recognition in the minor groove of DNA by pyrrole–imidazole polyamides to 9–13 base pairs. J. Am. Chem. Soc. 118, 6160–6166 (1996).
  Article CAS Google Scholar
• Swalley, S. E., Baird, E. E. & Dervan, P. B. A pyrrole–imidazole polyamide motif for recognition of eleven base pair sequences in the minor groove of DNA. Chem. Eur. J. 3, 1600–1607 (1997).
  Article CAS Google Scholar
• Wurtz, N. R. & Dervan, P. B. Sequence specific alkylation of DNA by hairpin pyrrole–imidazole polyamide conjugates. Chem. Biol. 7, 153–161 (2000).
  Article CAS PubMed Google Scholar
• Zhi-Fu, T., Fujiwara, T., Saito, I. & Sugiyama, H. Rational design of sequence-specific DNA alkylating agents based on duocarmycin A and pyrrole–imidazole hairpin polyamides. J. Am. Chem. Soc. 121, 4961–4967 (1999).
  Article Google Scholar
• Kohn, K. W., Hartley, J. A. & Mattes, W. B. Mechanisms of DNA sequence selective alkylation of guanine–N7 positions by nitrogen mustards. Nucleic Acids Res. 15, 10531–10549 (1987).The first critical insight based on experimental data for the origin of the sequence specificity of nitrogen mustards.
  Article CAS PubMed PubMed Central Google Scholar
• Seaman, F. & Hurley, L. H. Molecular basis for the DNA sequence selectivity of ecteinascidin 736 and 743: evidence for the dominant role of direct readout via hydrogen bonding. J. Am. Chem. Soc. 120, 13028–13041 (1998).
  Article CAS Google Scholar
• Tomasz, M. et al. Isolation and structure of a covalent cross-link adduct between mitomycin C and DNA. Science 235, 1204–1208 (1987).The long-sought-after structure of crosslinked DNA with mitomycin C.
  Article CAS PubMed Google Scholar
• Nielsen, P. E. Peptide nucleic acids as therapeutic agents. Curr. Opin. Struct. Biol. 9, 353–357 (1999).
  Article CAS PubMed Google Scholar
• Lohse, J. Dahl, O. & Nielsen, P. E. Double duplex invasion by peptide nucleic acid: a general principle for sequence-specific targeting of double stranded DNA. Proc. Natl Acad. Sci. USA 96, 11804–11808 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Majumdar, A. et al. Targeted gene knockout mediated by triple helix forming oligonucleotides. Nature Genet. 20, 212–214 (1998). A proof of principle that triple-helix technology can deliver the oligomer to the anticipated site in genomic DNA.
  Article CAS PubMed Google Scholar
• Giovannangeli, C. & Hélène, C. Triplex technology takes off. Nature Biotechnol. 18, 1245–1256 (2000).
  Article CAS Google Scholar
• Arimondo, P. B. et al. Design and optimization of camptothecin conjugates of triple helix-forming oligonucleotides for sequence-specfic DNA cleavage by topoisomerase I. J. Biol. Chem. 277, 3132–3140 (2002).
  Article CAS PubMed Google Scholar
• Keniry, M. A. Quadruplex structures in nucleic acids. Biopolymers (Nucleic Acid Sci.) 56, 123–146 (2001).
  Article CAS Google Scholar
• Gehring, K., Leroy, J. L. & Gueron, M. A tetrameric DNA structure with protonated cytosine·cytosine base pairs. Nature 363, 561–565 (1993).
  Article CAS PubMed Google Scholar
• Fang, G. & Cech, T. R. The β-subunit of Oxytricha telomere-binding protein promotes G-quartet formation by telomeric DNA. Cell 74, 875–885 (1993).
  Article CAS PubMed Google Scholar
• Sun, H., Bennett, R. J. & Maizels, N. The Saccharomyces cerevisiae Sgs1 helicase efficiently unwinds G–G paired DNAs. Nucleic Acids Res. 27, 1978–1984 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Damm, D. et al. A highly selective telomerase inhibitor limiting human cancer cell proliferation. EMBO J. 20, 6958–6968 (2001).The first small-molecule catalytic inhibitor of telomerase to be described in which telomere shortening and senescence characteristics were shown. The long time period that is required to produce these effects will be a challenge for clinical use.
  Article CAS PubMed PubMed Central Google Scholar
• Duan, W. et al. Design and synthesis of fluoroquinophenoxazines that interact with G-quadruplexes and their biological effects. Mol. Cancer Ther. 1, 103–120 (2001).
  CAS PubMed Google Scholar
• Hemann, M. T., Strong, M. A., Hao, L.-Y. & Greider, C. W. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107, 67–77 (2001).
  Article CAS PubMed Google Scholar
• Simonsson, T., Pecinka, P. & Kubista, M. DNA tetraplex formation in the control region of c-myc. Nucleic Acids Res. 26, 1167–1172 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Bazarov, A. V. et al. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to ras and raf transformation. Cancer Res. 61, 1178–1186 (2001).
  CAS PubMed Google Scholar
• Waters, J. S. et al. Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin's lymphoma. J. Clin. Oncol. 18, 1812–1823 (2000).The first demonstration of the clinical use of antisense therapy in treating cancer through downregulation of an oncogene.
  Article CAS PubMed Google Scholar
• Woynarowski, J. M., Trevino, A. V., Rodriguez, K. A., Hardies, S. C. & Benham, C. J. AT-rich islands in genomic DNA as a novel target for AT-specific DNA-reactive antitumor drugs. J. Biol. Chem. 276, 40555–40566 (2001).
  Article CAS PubMed Google Scholar
• Janssen, S., Cuvier, O., Müller, M. & Laemmli, U. K. Specific gain- and loss-of-function phenotypes induced by satellite-specific DNA-binding drugs fed to Drosophila melanogaster. Mol. Cell 6, 1013–1024 (2000).Proof of principle that polyamides can target A●T regions in a whole organism after oral administration.
  Article CAS PubMed Google Scholar
• Kohn, K. W., Shao, R. G. & Pommier, Y. How do drug-induced topoisomerase I–DNA lesions signal to the molecular interaction network that regulates cell cycle checkpoints, DNA replication, and DNA repair? Cell Biochem. Biophys. 33, 175–180 (2000).
  Article CAS PubMed Google Scholar
• Westin, L., Blomquist, P., Milligan, J. F. & Wrange, O. Triple helix DNA alters nucleosomal histone–DNA interactions and acts as a nucleosome barrier. Nucleic Acids Res. 23, 2184–2191 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Gottesfeld, J. M. et al. Sequence-specific recognition of DNA in the nucleosome by pyrrole–imidazole polyamides. J. Mol. Biol. 309, 615–629 (2001).
  Article CAS PubMed Google Scholar
• Portugal, J. Drug interactions with nucleosomes and chromatin. Methods Enzymol. 340, 503–518 (2001).
  Article CAS PubMed Google Scholar
• Han, H., Langley, D. R., Rangan, A. & Hurley, L. H. Selective interactions of cationic porphyrins with G-quadruplex structures. J. Am. Chem. Soc. 123, 8902–8913 (2001).
  Article CAS PubMed Google Scholar
• Rangan, A., Fedoroff, O. Y. & Hurley, L. H. Induction of duplex to G-quadruplex transition in the c-myc promoter region by a small molecule. J. Biol. Chem. 276, 4640–4646 (2001).
  Article CAS PubMed Google Scholar
• Bremer, R. E., Baird, E. E. & Dervan, P. B. Inhibition of major-groove-binding proteins by pyrrole–imidazole polyamides with an Arg–Pro–Arg positive patch. Chem. Biol. 5, 119–133 (1998).
  Article CAS PubMed Google Scholar
• Dervan, P. B. Molecular recognition of DNA by small molecules. Bioorg. Med. Chem. 9, 2215–2236 (2001).
  Article CAS PubMed Google Scholar